Rezolute hosts investor event on Ersodetug program; no specific data disclosed in filing

Rezolute, Inc.

Company held investor event on November 10, 2025, to update Ersodetug development program.
Presentation filed as Exhibit 99.1 contains no numerical or clinical data in provided text.
Forward-looking statements caution regarding actual results differing from expectations.
No material financial or regulatory changes disclosed in the 8-K or exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.